Hackel M - Search Results

1

BWC0977, a broad-spectrum antibacterial clinical candidate to treat multidrug resistant infections.

Hameed P S, Kotakonda H, Sharma S, Nandishaiah R, Katagihallimath N, Rao R, Sadler C, Slater I, Morton M, Chandrasekaran A, Griffen E, Pillai D, Reddy S, Bharatham N, Venkatesan S, Jonnalagadda V, Jayaraman R, Nanjundappa M, Sharma M, Raveendran S, Rajagopal S, Tumma H, Watters A, Becker H, Lindley J, Flamm R, Huband M, Sahm D, Hackel M, Mathur T, Kolamunnage-Dona R, Unsworth J, Mcentee L, Farrington N, Manickam D, Chandrashekara N, Jayachandiran S, Reddy H, Shanker S, Richard V, Thomas T, Nagaraj S, Datta S, Sambandamurthy V, Ramachandran V, Clay R, Tomayko J, Das S, V B. Hameed P S, et al. Among authors: hackel m. Nat Commun. 2024 Sep 18;15(1):8202. doi: 10.1038/s41467-024-52557-2. Nat Commun. 2024. PMID: 39294149 Free PMC article. Clinical Trial.

2

In Vitro Activity of AZD0914, a Novel Bacterial DNA Gyrase/Topoisomerase IV Inhibitor, against Clinically Relevant Gram-Positive and Fastidious Gram-Negative Pathogens.

Biedenbach DJ, Huband MD, Hackel M, de Jonge BL, Sahm DF, Bradford PA. Biedenbach DJ, et al. Among authors: hackel m. Antimicrob Agents Chemother. 2015 Oct;59(10):6053-63. doi: 10.1128/AAC.01016-15. Epub 2015 Jul 20. Antimicrob Agents Chemother. 2015. PMID: 26195518 Free PMC article.

3

In Vitro Activity of Gepotidacin, a Novel Triazaacenaphthylene Bacterial Topoisomerase Inhibitor, against a Broad Spectrum of Bacterial Pathogens.

Biedenbach DJ, Bouchillon SK, Hackel M, Miller LA, Scangarella-Oman NE, Jakielaszek C, Sahm DF. Biedenbach DJ, et al. Among authors: hackel m. Antimicrob Agents Chemother. 2016 Jan 4;60(3):1918-23. doi: 10.1128/AAC.02820-15. Antimicrob Agents Chemother. 2016. PMID: 26729499 Free PMC article.

4

Etiology, extended-spectrum β-lactamase rates and antimicrobial susceptibility of gram-negative bacilli causing intra-abdominal infections in patients in general pediatric and pediatric intensive care units--global data from the Study for Monitoring Antimicrobial Resistance Trends 2008 to 2010.

Badal RE, Bouchillon SK, Lob SH, Hackel MA, Hawser SP, Hoban DJ. Badal RE, et al. Pediatr Infect Dis J. 2013 Jun;32(6):636-40. doi: 10.1097/INF.0b013e3182886377. Pediatr Infect Dis J. 2013. PMID: 23838732

5

Multidrug-resistant Gram-negative bacilli recovered from respiratory and blood specimens from adults: the ATLAS surveillance program in European hospitals, 2018-2020.

Humphries RM, Janssen H, Hey-Hadavi JH, Hackel M, Sahm D. Humphries RM, et al. Among authors: hackel m. Int J Antimicrob Agents. 2023 Feb;61(2):106724. doi: 10.1016/j.ijantimicag.2023.106724. Epub 2023 Jan 13. Int J Antimicrob Agents. 2023. PMID: 36642231 Free article.

6

Activity of imipenem/relebactam and comparators against gram-negative pathogens from patients with bloodstream infections in the United States and Canada - SMART 2018-2019.

Lob SH, Hackel MA, Young K, Motyl MR, Sahm DF. Lob SH, et al. Diagn Microbiol Infect Dis. 2021 Aug;100(4):115421. doi: 10.1016/j.diagmicrobio.2021.115421. Epub 2021 May 7. Diagn Microbiol Infect Dis. 2021. PMID: 34082265

7

In Vitro Activity of Ceftibuten/VNRX-5236 against Urinary Tract Infection Isolates of Antimicrobial-Resistant Enterobacterales.

Karlowsky JA, Hackel MA, Sahm DF. Karlowsky JA, et al. Antimicrob Agents Chemother. 2022 Jan 18;66(1):e0130421. doi: 10.1128/AAC.01304-21. Epub 2021 Oct 18. Antimicrob Agents Chemother. 2022. PMID: 34662183 Free PMC article.

8

In Vitro Activity of WCK 5222 (Cefepime-Zidebactam) against Worldwide Collected Gram-Negative Bacilli Not Susceptible to Carbapenems.

Karlowsky JA, Hackel MA, Bouchillon SK, Sahm DF. Karlowsky JA, et al. Antimicrob Agents Chemother. 2020 Nov 17;64(12):e01432-20. doi: 10.1128/AAC.01432-20. Print 2020 Nov 17. Antimicrob Agents Chemother. 2020. PMID: 32928739 Free PMC article.

9

Ceftibuten-Ledaborbactam Activity against Multidrug-Resistant and Extended-Spectrum-β-Lactamase-Positive Clinical Isolates of Enterobacterales from a 2018-2020 Global Surveillance Collection.

Karlowsky JA, Wise MG, Hackel MA, Pevear DC, Moeck G, Sahm DF. Karlowsky JA, et al. Antimicrob Agents Chemother. 2022 Nov 15;66(11):e0093422. doi: 10.1128/aac.00934-22. Epub 2022 Oct 26. Antimicrob Agents Chemother. 2022. PMID: 36286518 Free PMC article.

10

In vitro antibacterial activities of cefiderocol against Gram-negative clinical strains isolated from China in 2020.

Kohira N, Hackel MA, Oota M, Takemura M, Hu F, Mizuno H, Sahm DF, Yamano Y. Kohira N, et al. Among authors: hackel ma. J Glob Antimicrob Resist. 2023 Mar;32:181-186. doi: 10.1016/j.jgar.2022.11.017. Epub 2022 Dec 10. J Glob Antimicrob Resist. 2023. PMID: 36513320 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

115 results

Search Page

Filters